A detailed history of Ballentine Partners, LLC transactions in Stryker Corp stock. As of the latest transaction made, Ballentine Partners, LLC holds 7,041 shares of SYK stock, worth $2.58 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,041
Previous 7,023 0.26%
Holding current value
$2.58 Million
Previous $2.39 Million 6.45%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$315.94 - $371.96 $5,686 - $6,695
18 Added 0.26%
7,041 $2.54 Million
Q2 2024

Aug 06, 2024

SELL
$324.3 - $354.67 $5,188 - $5,674
-16 Reduced 0.23%
7,023 $2.39 Million
Q1 2024

Apr 11, 2024

BUY
$293.94 - $358.71 $53,203 - $64,926
181 Added 2.64%
7,039 $2.52 Million
Q4 2023

Jan 23, 2024

BUY
$253.85 - $299.46 $271,619 - $320,422
1,070 Added 18.49%
6,858 $2.05 Million
Q3 2023

Oct 19, 2023

BUY
$266.54 - $302.43 $13,060 - $14,819
49 Added 0.85%
5,788 $1.58 Million
Q2 2023

Jul 26, 2023

SELL
$271.49 - $305.09 $112,125 - $126,002
-413 Reduced 6.71%
5,739 $1.75 Million
Q1 2023

Apr 27, 2023

BUY
$246.13 - $285.47 $176,475 - $204,681
717 Added 13.19%
6,152 $1.76 Million
Q4 2022

Jan 27, 2023

BUY
$205.51 - $253.93 $4,932 - $6,094
24 Added 0.44%
5,435 $0
Q3 2022

Oct 26, 2022

BUY
$189.27 - $231.83 $20,441 - $25,037
108 Added 2.04%
5,411 $1.1 Million
Q2 2022

Aug 09, 2022

SELL
$194.09 - $276.37 $4,464 - $6,356
-23 Reduced 0.43%
5,303 $1.05 Million
Q1 2022

May 05, 2022

BUY
$245.33 - $277.77 $39,007 - $44,165
159 Added 3.08%
5,326 $1.42 Million
Q4 2021

Feb 14, 2022

BUY
$236.63 - $276.44 $309,985 - $362,136
1,310 Added 33.96%
5,167 $1.38 Million
Q3 2021

Oct 27, 2021

BUY
$248.9 - $280.09 $2,986 - $3,361
12 Added 0.31%
3,857 $1.02 Million
Q2 2021

Aug 12, 2021

SELL
$242.95 - $267.0 $58,550 - $64,347
-241 Reduced 5.9%
3,845 $1 Million
Q1 2021

May 11, 2021

SELL
$221.01 - $248.82 $25,637 - $28,863
-116 Reduced 2.76%
4,086 $994,000
Q4 2020

Jan 25, 2021

SELL
$202.01 - $245.04 $71,107 - $86,254
-352 Reduced 7.73%
4,202 $1.03 Million
Q3 2020

Oct 22, 2020

BUY
$177.77 - $215.81 $3,910 - $4,747
22 Added 0.49%
4,554 $949,000
Q2 2020

Jul 31, 2020

BUY
$144.67 - $207.03 $3,906 - $5,589
27 Added 0.6%
4,532 $816,000
Q1 2020

Apr 23, 2020

BUY
$126.5 - $225.1 $7,590 - $13,506
60 Added 1.35%
4,505 $749,000
Q4 2019

Jan 22, 2020

SELL
$197.98 - $220.53 $16,630 - $18,524
-84 Reduced 1.85%
4,445 $933,000
Q3 2019

Oct 21, 2019

SELL
$205.4 - $221.82 $5,135 - $5,545
-25 Reduced 0.55%
4,529 $980,000
Q2 2019

Jul 25, 2019

BUY
$180.24 - $205.58 $62,543 - $71,336
347 Added 8.25%
4,554 $935,000
Q1 2019

May 09, 2019

BUY
$152.46 - $198.0 $4,116 - $5,346
27 Added 0.65%
4,207 $832,000
Q4 2018

Feb 04, 2019

BUY
$145.0 - $178.65 $7,830 - $9,647
54 Added 1.31%
4,180 $656,000
Q3 2018

Oct 30, 2018

BUY
$163.25 - $177.68 $6,040 - $6,574
37 Added 0.9%
4,126 $734,000
Q2 2018

Jul 19, 2018

BUY
$155.17 - $179.78 $2,327 - $2,696
15 Added 0.37%
4,089 $691,000
Q1 2018

Apr 26, 2018

BUY
$148.01 - $168.91 $6,956 - $7,938
47 Added 1.17%
4,074 $656,000
Q4 2017

Feb 02, 2018

SELL
$143.51 - $159.74 $10,476 - $11,661
-73 Reduced 1.78%
4,027 $623,000
Q3 2017

Nov 06, 2017

BUY
$138.36 - $147.87 $567,276 - $606,267
4,100
4,100 $581,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $139B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.